Oak Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.9M | Buy |
|
|||||
|
2025
Q2 | $4.3M | Sell |
|
|||||
|
2025
Q1 | $6.24M | Hold |
|
|||||
|
2024
Q4 | $7M | Sell |
|
|||||
|
2024
Q3 | $10.4M | Buy |
|
|||||
|
2024
Q2 | $10.3M | Hold |
|
|||||
|
2024
Q1 | $9.46M | Hold |
|
|||||
|
2023
Q4 | $8.63M | Hold |
|
|||||
|
2023
Q3 | $8.09M | Buy |
|
|||||
|
2023
Q2 | $7.04M | Sell |
|
|||||
|
2023
Q1 | $8.05M | Hold |
|
|||||
|
2022
Q4 | $7.07M | Buy |
|
|||||
|
2022
Q3 | $2.69M | Hold |
|
|||||
|
2022
Q2 | $2.31M | Buy |
|
|||||
|
2022
Q1 | $2.5M | Hold |
|
|||||
|
2021
Q4 | $2.26M | Hold |
|
|||||
|
2021
Q3 | $2.16M | Hold |
|
|||||
|
2021
Q2 | $2M | Hold |
|
|||||
|
2021
Q1 | $1.69M | Buy |
|
|||||
|
2020
Q4 | $1.54M | Buy |
|
|||||
|
2020
Q3 | $1.68M | Buy |
|
|||||
|
2020
Q2 | $864K | Buy |
|